---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-008947"
form_type: "8-K"
ticker: "PMCB"
cik: "0001157075"
company_name: "PharmaCyte Biotech, Inc."
filed_at: "2025-12-05T23:59:59+00:00"
generated_at: "2026-05-16T14:12:20.284004+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PharmaCyte Biotech receives Nasdaq notice of non-compliance with $1.00 minimum bid price

## Summary
- Notice received Dec 1, 2025; stock closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until June 1, 2026, to regain compliance.
- To regain compliance, closing bid price must be at least $1.00 for 10 consecutive business days.
- If not cured by June 1, 2026, Company may seek a second 180-day period or face delisting.
- Options under consideration include a reverse stock split, subject to stockholder approval.

## SEC filing metadata
- accession: 0001683168-25-008947
- form_type: 8-K
- ticker: PMCB
- cik: 0001157075
- company_name: PharmaCyte Biotech, Inc.
- filed_at: 2025-12-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157075/000168316825008947/0001683168-25-008947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157075/000168316825008947/pharmacyte_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-008947
- JSON: https://secwatch.observer/filing/0001683168-25-008947.json
- Plain text: https://secwatch.observer/filing/0001683168-25-008947.txt

## Source-grounded claims
- claim_id: a73c0f3b22208ca4191c369613f48c723719a43a
  claim: PharmaCyte Biotech, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A), 5810(c)(3)(H)).
  evidence_excerpt: In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until June 1, 2026 (the “Compliance Date”), to regain compliance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1157075/000168316825008947/0001683168-25-008947-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.